Gene Query: CDKN2B

Dataset Description Geneva Score
MYCi361 regulates MYC target genes 145.56
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 137.68
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 137.68
IL-33 activates tumor stroma to promote intestinal polyposis 115.68
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 115.27
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 73.05
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 68.71
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 65.57
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 65.52
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 56.91
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 56.43
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 56.36
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 55.74
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 55.21
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 54.02
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 52.93
Differential analysis of gene regulation at transcript resolution by RNA-Seq 52.93
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 52.27
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 51.68
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 51.68
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 48.38
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 48.15
Crizotinib v. DMSO in SW480 cells 47.22
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 47.18
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 45.65
Proliferation-correlated expression 45.55
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 45.3
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 44.17
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 44.17
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 43.28
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 42.9
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 42.22
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 42.01
Gene expression analysis of dengue-infected cells 41.83
Gene expression changes upon drug withdrawal (Mel888 cell line) 41.53
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 40.56
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 40.29
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 40.19
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 39.45
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 39.38
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 39.38
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 38.36
Identification of Sin3B regulated genes during quiescence 37.74
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 37.01
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 36.16
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 35.53
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 34.54
Generation of KRAS signatures using immortalized isogenic lung cells. 33.82
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 33.6
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 33.43
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 32.78
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 32.66
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 32.55
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 31.51
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 30.9
Effect of BMP inhibition or stimulation of primary human keratinocytes 30.9
Fbxo32 mediated gene expression program underlies EMT and metastasis 30.59
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 30.33
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 30.29
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 29.97
Toxoplasma gondii infection of human retinal pigment epithelial cells 29.69
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 29.23
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 29.19
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 28.29
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 27.74
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 27.72
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 27.41
RNA-sequencing in immortalized human mammary epithelial cells 27.41
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 27.26
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 27.26
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 26.88
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 26.38
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 26.19
High-Throughput Kinetic Analysis of Fractional Killing 26.0
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 25.95
Global expression profiles in cardiac progenitor cells generated by ISX-9 25.93
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 25.93
AR-independent prostate cancer is sustained through FGF signaling 25.83
Differential gene expression in Jagged1 treated human dental pulp cells. 25.81
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 25.07
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 24.9
Transcriptional effect of ETV1 knockdown in melanoma cells 24.82
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 24.8
RNA-seq of young and quiescent MRC-5 human fibroblasts 24.69
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 24.6
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 24.54
Modeling Familial Cancer with iPSC Approaches 23.84
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 23.76
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 23.56
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 23.51
Transcriptomic and gene ontology profiling of the human corneal cell types 23.48
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 23.43
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 23.27
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 23.17
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 23.14
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 22.9
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 22.79
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 22.32
MYCi975 regulates MYC target genes 22.14
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 22.03
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 21.75
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 21.59
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 21.59
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 21.57
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 21.57
Overexpression and knockdown experiment for circCSNK1G3 21.45
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 21.21
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 21.21
Integrin signaling regulates YAP/TAZ to control skin homeostasis 21.0
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 20.93
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 20.64
Silencing p300 in MCF7 cells to study expression and alternative splicing 20.45
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 20.28
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 20.18
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 20.08
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 20.04
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 19.91
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 19.6
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 19.56
Postnatal lipids drive hepatocyte maturation 19.51
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 19.49
RNA-sequencing of healthy human skeletal myocytes 19.44
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 19.4
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 19.4
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 19.39
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 19.39
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 19.25
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 19.25
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 19.11
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 19.11
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 19.05
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 18.94
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 18.89
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 18.84
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 18.7
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 18.51
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 18.41
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 18.41
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 18.36
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 18.28
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 18.23
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 18.18
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 18.12
Generation of trichogenic adipose-derived stem cells by expression of three factors 17.78
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 17.7
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 17.69
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 17.51
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 17.5
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 17.47
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 17.35
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 17.18
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 17.18
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 17.14
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 17.12
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 17.02
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 17.02
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 16.69
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 16.45
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 16.45
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 16.45
Effect of ILF3 on translation during homeostasis and the antiviral response 16.42
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 16.38
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 16.21
Disruption of the exocyst induces podocyte loss and dysfunction 15.95
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 15.81
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 15.81
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 15.7
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 15.6
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 15.59
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 15.49
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 15.47
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 15.45
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 15.16
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 15.15
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 15.08
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 15.07
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 15.07
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 15.03
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 14.96
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 14.88
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 14.72
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 14.68
STRIPAK directs PP2A activity to promote oncogenic transformation 14.6
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 14.59
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 14.32
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 14.29
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 14.23
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 14.23
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 14.16
HNF1 regulates critical functions of the human epididymis epithelium. 14.16
NR2F2 study 14.13
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 14.13
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 14.06
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 13.99
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 13.95
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 13.94
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 13.9
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 13.87
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 13.86
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 13.86
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 13.83
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 13.83
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 13.79
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 13.7
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 13.56
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 13.54
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 13.53
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 13.46
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 13.44
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 13.41
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 13.32
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 13.17
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 13.12
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 12.85
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 12.79
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 12.63
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 12.55
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 12.4
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 12.34
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 12.33
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 12.22
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 12.2
Co-regulation of splicing by Rbfox1 and hnRNP M 12.2
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 12.11
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 12.01
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 12.01
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 11.98
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 11.88
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 11.86
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 11.86
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 11.77
Capturing the Interactome of Newly Transcribed RNA (RICK) 11.76
Capturing the Interactome of Newly Transcribed RNA 11.76
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 11.75
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 11.71
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 11.67
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 11.44
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 11.43
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 11.39
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 11.29
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 11.28
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 11.23
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 11.22
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 11.2
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 11.16
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 11.14
Control of prostate tumour growth by the long non-coding RNA GHSROS 11.12
Cerebellar differentiation in Ataxia-Telangiectasia 11.09
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 11.09
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 11.08
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 11.03
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 11.03
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 10.98
Rorc disruption in human FG pancreatic cancer cells 10.94
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 10.89
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 10.83
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 10.76
RNA-seq analysis of RALD iPSCs after in vitro differentiation 10.71
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 10.7
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 10.63
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 10.58
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 10.58
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 10.52
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 10.45
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 10.45
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 10.42
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 10.36
Hepatitis C virus functionally sequesters miR-122 10.29
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 10.29
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 10.28
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 10.21
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 10.21
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 10.07
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 10.06
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 10.05
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 10.01
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 9.95
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 9.95
Survival of pancreatic cancer cells lacking KRAS function 9.92
RNA-seq analyisis of PUM2 knockout cells 9.9
BAF controls genome accessibility 9.84
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 9.82
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 9.78
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 9.77
RNA-seq analysis of breast cancer 9.53
RNA-seq analysis and shRNA screen of breast cancer 9.53
RNAseq of IL-36 stimulated primary human keratinocytes 9.51
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 9.44
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 9.28
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 9.26
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 9.23
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 9.21
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 9.21
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 9.18
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 9.17
Developmental stage specific chromosome architecture in human erythroid cells 9.17
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 9.1
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 9.04
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 9.01
Epigenome regulation during epidermal lineage commitment [RNA-seq] 8.84
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 8.71
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 8.64
Total RNA sequencing of APC mutant and wt colonic organoids 8.64
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 8.6
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 8.55
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 8.49
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 8.41
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 8.4
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 8.33
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 8.31
Recovery and analysis of nascent RNA 8.31
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 8.17
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 8.17
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 8.1
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 8.1
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 8.1
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 8.09
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 8.03
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 8.0
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 7.98
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 7.91
Statins modulate endothelial transcriptional profile by inhibiting EZH2 7.91
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 7.86
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 7.81
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 7.67
RNA-seq of YB5 cells treated with Proscillaridin A 7.61
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 7.47
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 7.38
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 7.31
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 7.15
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 7.15
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 6.99
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 6.99
iPSC-Derived Cholangiocytes 6.9
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 6.9
Paxillin regulates genomic networks in prostate cancer [PC3] 6.88
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 6.83
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 6.81
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 6.81
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 6.74
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 6.74
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 6.74
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 6.71
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 6.71
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 6.7
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 6.66
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 6.64
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 6.58
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 6.5
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 6.32
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 6.32
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 6.23
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 6.19
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 6.16
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 6.15
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 6.09
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 6.06
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 6.03
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 6.01
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 5.98
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 5.97
Ectoderm specification of H1 human embryonic stem cells 5.95
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 5.93
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 5.88
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 5.87
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 5.83
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 5.79
Investigation about fibroblasts of different origins in culture 5.55
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 5.54
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 5.42
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 5.36
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 5.19
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 5.17
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 5.17
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 5.13
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 5.1
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 5.1
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 5.05
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 5.03
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 4.97
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 4.97
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 4.97
RNA-seq of shEZH2 cells 4.96
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 4.95
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 4.9
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 4.84
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 4.8
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 4.6
RNA sequencing of human pancreatic cancer cell lines 4.6
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 4.56
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 4.54
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 4.52
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 4.48
Neurofibroma 4.34
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 4.34
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 4.31
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 4.19
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 4.16
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 4.08
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 4.08
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 3.96
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 3.96
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 3.83
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 3.83
3.74
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 3.74
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 3.65
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 3.62
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 3.62
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 3.6
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 3.6
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 3.6
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 3.54
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 3.5
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 3.45
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 3.41
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 3.35
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 3.24
RNA-Seq in PWS iPSC-derived neurons 3.09
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 2.97
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 2.94
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 2.93
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 2.9
Functional Haploid Human Oocytes Generated from Polar Body Genomes 2.85
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 2.85
Novel Targeting of Transcription and Metabolism in Glioblastoma 2.82
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 2.73
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 2.73
MCF-7 as a model for functional analysis of breast cancer risk variants 2.7
Trascriptome of thyroid cancer-induced macrophages 2.66
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 2.57
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 2.56
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 2.56
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 2.52
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 2.49
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 2.47
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 2.47
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 2.4
DRB/GRO-Seq -/+ UV 2.39
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 2.34
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 2.29
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 2.23
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 2.17
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 2.14
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 2.14
p63 controls the enhancer landscape during keratinocyte differentiation 2.12
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 2.06
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 2.0
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 2.0
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 1.9
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 1.8
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 1.73
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 1.73
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 1.71
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 1.71
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 1.66
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 1.64
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 1.64
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 1.58
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 1.58
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 1.58
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 1.5
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 1.5
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 1.44
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 1.41
Gene expression analysis in response to hypoxic pathway inhibition 1.31
Gene expression of thyroid cancer cell lines 1.29
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 1.26
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 1.2
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 1.2
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 1.17
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 1.14
Gene expression analysis of human adenomas. 1.09
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 1.06
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.98
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 0.97
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.94
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 0.93
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 0.89
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 0.86
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 0.84
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.7
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.7
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 0.69
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.66
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 0.62
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 0.49
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.48
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.42
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.36
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 0.35
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 0.35
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.3
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.2
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.2
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.2
Transcriptomic analysis of frontal fibrosing alopecia 0.15
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 0.02
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 0.02
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation